• Home
  • About
  • Investors
  • Science
  • Announcements
cardiogeni.com

Update on Conditional Share Exchange Agreement

by Darrin Disley | Apr 13, 2026 | Uncategorized

13 April 2026 Cardiogeni PLC (“Cardiogeni”, “CGNI” or the “Company”) Update on Share Exchange Agreement with Kira Health Invest AG Cardiogeni (AQSE: CGNI), a UK clinical stage biotechnology company founded by 2007 Nobel Laureate Sir Martin...

Update on Conditional Share Exchange Agreement

by Darrin Disley | Apr 1, 2026 | Uncategorized

1st April 2026 Cardiogeni PLC (“Cardiogeni”, “CGNI” or the “Company”) Update on Share Exchange Agreement with Kira Health Invest AG Cardiogeni (AQSE: CGNI), a UK clinical stage biotechnology company founded by 2007 Nobel Laureate Sir Martin...

Cardiogeni Plc – Conditional Share Exchange Agreement

by Darrin Disley | Mar 16, 2026 | Uncategorized

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (“UK MAR”). IN ADDITION,...
Next Entries »
Cardiogeni is committed to advancing pioneering cellular therapies that repair and reactivate heart tissue leading to improved heart health. Guided by world-leading science, commercial excellence and a dedication to patient impact, we strive to deliver safe, effective, and life-changing solutions for those living with heart failure.

Navigation

  • Home
  • About
  • Investors
  • Science
  • Announcements

Socials

  • Follow

Address

Cardiogeni Plc
Celixir House,
Innovation Way,
Stratford-Upon-Avon,
England,
CV37 7GZ

© 2025 Cardiogeni. All rights reserved.

Terms and Conditions | Privacy Policy

Designed By: